Keyword: London

The fund will back pharma companies as well as developers of medtech products and providers of outsourced services.

Based on AI analysis of heart MRI images from UK Biobank, scientists linked genetic factors to 22% to 39% of abnormalities in the heart’s left ventricle.

Trials for cancer drugs undertaken in Europe in the mid-2010s were flawed to such a degree as to “raise questions” over their true benefit to patients.

U.S.-London CRO Phastar has hired Jennifer Bradford, Ph.D., to lead its data science group.

The VC plans to pump $150 million into biotechs that are working to extend use of advanced therapies to major diseases such as diabetes.

AI in drug development is among the hottest buzzwords in biopharma right now, but real progress is hampered by lack of expertise and access.

Allergy Therapeutics saw its stock down 40% in early trading in London after its birch pollen drug failed to move the needle in a key phase 3 trial.

FundamentalVR has added haptic glove compatibility to its VR surgeon training system so they can feel the shape and weight of simulated 3D objects.

The actions are part of the biotech’s ongoing efforts to seek a way out of its R&D-triggered troubles. 

The fund will pump the money into biotechs and other longevity startups based around the world in seed to series B rounds.